|Articles|December 7, 2011
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-12-07-2011
- Volume 7
- Issue 12
Technical Perspectives: Antibody Drug Conjugates
Author(s)Patricia Van Arnum
A podcast moderated by Patricia Van Arnum, executive editor of Pharmaceutical Technology.
Advertisement
Antibody drug conjugates represent a niche area of drug development. Antibody drug conjugates combine a small-molecule, often a cytotoxic compound, to a monoclonal antibody. Grant E. Boldt, PhD, director of European business development for SAFC, discusses manufacturing considerations in producing antibody drug conjugates with Patricia Van Arnum, executive editor of Pharmaceutical Technology. Listen to the
Articles in this issue
over 14 years ago
CSR and Sustainability in the Newsover 14 years ago
Pharmaceutical Companies Target Green Manufacturingover 14 years ago
Biosimilars' Technology NeedsAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What to Know About Regulations in June 2026
2
BioPhorum Unites 20 Organizations to Modernize Small Molecule Production
3
Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers
4
FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients
5